Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,775 | 259 | 91.7% |
| Education | $523.69 | 20 | 8.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius USA Marketing, Inc. | $987.66 | 56 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $811.47 | 35 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $703.71 | 22 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $456.05 | 15 | $0 (2019) |
| Amgen Inc. | $431.12 | 17 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $374.47 | 20 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $368.91 | 21 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $329.04 | 15 | $0 (2024) |
| Relypsa, Inc. | $308.35 | 17 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $195.95 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,028 | 55 | Fresenius USA Marketing, Inc. ($271.40) |
| 2023 | $912.75 | 36 | Mallinckrodt Hospital Products Inc. ($234.87) |
| 2022 | $923.12 | 33 | Mallinckrodt Hospital Products Inc. ($235.15) |
| 2021 | $750.53 | 27 | AstraZeneca Pharmaceuticals LP ($387.90) |
| 2020 | $490.97 | 27 | Fresenius USA Marketing, Inc. ($125.12) |
| 2019 | $1,016 | 44 | Mallinckrodt Enterprises LLC ($211.54) |
| 2018 | $638.34 | 33 | Mallinckrodt LLC ($175.67) |
| 2017 | $538.24 | 24 | Merck Sharp & Dohme Corporation ($153.37) |
All Payment Transactions
279 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Cardio-renal | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/22/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $32.38 | General |
| Category: Immunology | ||||||
| 11/13/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: Catheter Lock Solution | ||||||
| 11/07/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $29.98 | General |
| 09/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Cardio-renal | ||||||
| 09/13/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/05/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/23/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/15/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Phosphate binder for ESRD | ||||||
| 07/18/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Phosphate binder for ESRD | ||||||
| 07/09/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 07/09/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 07/02/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 07/02/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $3.80 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 06/13/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: IMMUNOLOGY | ||||||
| 06/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Cardio-renal | ||||||
| 06/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Obesity | ||||||
| 05/31/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/24/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/21/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $17.96 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,137 | 2,890 | $677,374 | $233,375 |
| 2022 | 11 | 1,231 | 3,117 | $763,297 | $257,579 |
| 2021 | 11 | 1,400 | 3,597 | $908,277 | $314,134 |
| 2020 | 12 | 1,654 | 4,121 | $1.2M | $366,787 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 343 | 1,273 | $224,048 | $74,450 | 33.2% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 38 | 194 | $132,114 | $50,890 | 38.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 218 | 296 | $97,384 | $28,271 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 151 | 241 | $52,538 | $20,850 | 39.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 113 | 430 | $40,850 | $15,598 | 38.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 30 | 65 | $37,180 | $14,159 | 38.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 83 | 182 | $32,214 | $9,590 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 92 | 116 | $19,836 | $7,023 | 35.4% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 18 | 42 | $18,522 | $6,275 | 33.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 29 | 29 | $14,152 | $3,744 | 26.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $8,536 | $2,525 | 29.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 373 | 1,386 | $243,936 | $73,213 | 30.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 42 | 233 | $158,673 | $62,748 | 39.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 210 | 277 | $91,133 | $27,560 | 30.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 179 | 291 | $63,438 | $25,192 | 39.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 34 | 100 | $57,309 | $22,197 | 38.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 84 | 231 | $40,887 | $12,560 | 30.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 108 | 376 | $35,720 | $10,811 | 30.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 53 | 53 | $25,864 | $7,707 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 83 | 98 | $16,758 | $6,097 | 36.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $18,624 | $5,815 | 31.2% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 17 | 24 | $10,955 | $3,679 | 33.6% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 50 | 347 | $236,307 | $93,526 | 39.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 393 | 1,482 | $260,832 | $80,919 | 31.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 255 | 364 | $119,756 | $37,302 | 31.1% |
About Dr. Fadi Daher, M.D
Dr. Fadi Daher, M.D is a Nephrology healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1164554572.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fadi Daher, M.D has received a total of $6,298 in payments from pharmaceutical and medical device companies, with $1,028 received in 2024. These payments were reported across 279 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($5,775).
As a Medicare-enrolled provider, Daher has provided services to 5,422 Medicare beneficiaries, totaling 13,725 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Memphis, TN
- Active Since 03/12/2007
- Last Updated 02/26/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1164554572
Products in Payments
- ACTHAR (Biological) $1,160
- Velphoro (Drug) $787.64
- LOKELMA (Drug) $579.06
- JYNARQUE (Drug) $375.02
- Kerendia (Drug) $374.47
- Veltassa (Drug) $329.96
- LUPKYNIS (Drug) $329.04
- FARXIGA (Drug) $204.63
- ZEPATIER (Drug) $195.95
- Parsabiv (Biological) $155.11
- AVYCAZ (Drug) $124.11
- KRYSTEXXA (Biological) $123.42
- Prolia (Biological) $105.87
- Parsabiv (Drug) $104.86
- Envarsus (Drug) $95.84
- Dialyzers (Device) $94.57
- RAYALDEE (Drug) $66.09
- BENLYSTA (Biological) $65.01
- Fabhalta (Drug) $60.51
- AURYXIA (Drug) $59.51
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Memphis
Dr. Omar Davis, M.d, M.D
Nephrology — Payments: $57,405
Dr. Natarsha Grant, Md, MD
Nephrology — Payments: $34,340
Dr. Robert Canada, Md, MD
Nephrology — Payments: $21,903
Dr. Wael Hussein
Nephrology — Payments: $15,498
Minesh Pathak, M.d, M.D
Nephrology — Payments: $13,583
L Quarles, M.d, M.D
Nephrology — Payments: $12,060